Industry
Medical (M)
43 patents · 5 cases in this industry. Sorted by number of in-industry cases.
- US115898801 case →6/8 sections
A concise summary of U.S. Patent No. 11,589,880, including a plain-language overview of its independent claims, is provided below. The patent is the subject of a lawsuit filed by AngioDynamics, Inc. against Endovascular Engineering, Inc…
- US121616281 case →6/8 sections
Summary of U.S. Patent No. 12,161,628 Title: Combination therapy Assignee: Astellas Pharma Inc., Medivation Prostate Therapeutics LLC Inventors: Jacqueline GIBBONS, Joyce MORDENTI, Michiel DE VRIES, Walter KRAUWINKEL, Taoufik Ouatas Filing…
- US125023571 case →6/8 sections
As a senior US patent analyst, I have reviewed the provided information for US patent 12502357. Below is a concise summary based on the authoritative patent text. Summary of US Patent 12502357 Title: Formulations of enzalutamide Assignee…
An analysis of U.S. Patent 9,549,918 reveals a focus on improving the stability of the immunosuppressant drug tacrolimus in pharmaceutical formulations. As of the current date, there is no indication of active litigation involving this…
- US124030951 case →3/8 sections
Analysis of U.S. Patent 12,403,095: Stabilized Tacrolimus Composition Date of Analysis: May 1, 2026 A detailed review of U.S. Patent 12,403,095 has been conducted. This document, titled "Stabilized tacrolimus composition," was issued on…
- US116239201 case →2/8 sections
Patent Analyst Report: US 11,623,920 B2 Date of Analysis: 2026-05-05 Subject: United States Patent 11,623,920 B2 This report provides a concise summary of US patent 11,623,920, including its key bibliographic data and a plain-language…
- US118396891 case →2/8 sections
A technical analysis of U.S. Patent 11,839,689 reveals it pertains to specific formulations of the prostate cancer drug enzalutamide, designed to improve its solubility and absorption. The patent is currently active and has been asserted…
- US120831031 case →2/8 sections
Patent Summary: US 12,083,103 B2 Title: Tacrolimus for improved treatment of transplant patients Assignee: Veloxis Pharmaceuticals Inc. Inventors: Robert D. Gordon, Per Holm, Anne-Marie Lademann, Tomas Norling Filing Date: August 4, 2021…
Analysis of U.S. Patent 8,613,717 Date of Analysis: April 26, 2026 This report provides a summary of United States Patent 8,613,717, including its key bibliographic details and a plain-language explanation of its independent claims. ---…
- US111233311 case →1/8 sections
A concise summary of US Patent 11,123,331 is as follows: Title: Tacrolimus for improved treatment of transplant patients Assignee: Veloxis Pharmaceuticals, Inc. Inventors: Robert D. Gordon, Per Holm, Anne-Marie Lademann, Tomas Norling…
- US114198231 case →1/8 sections
As a senior US patent analyst, I have reviewed the provided documentation for US patent 11,419,823. While I cannot perform a live search of the USPTO database or CAFC dockets, the provided patent text contains the necessary information…
- US124960771 case →1/8 sections
An analysis of U.S. Patent 12,496,077 has been conducted based on the provided documentation. Summary of U.S. Patent 12,496,077 Title: Systems and methods for removing undesirable material within a circulatory system Assignee…
Patent Summary: US 8,664,239 B2 Title: Tacrolimus for improved treatment of transplant patients Assignee: Veloxis Pharmaceuticals Inc. Inventors: Robert D. Gordon, Per Holm, Anne-Marie Lademann, Tomas Norling Filing Date: June 23, 2011…
Summary of U.S. Patent No. 8,685,998 A concise summary of U.S. Patent No. 8,685,998 is provided below, based on a review of the United States Patent and Trademark Office (USPTO) database. A search of the 2026 dockets for the Court of…
- US101661901 case →0/8 sections
Summary not yet generated.
- US108641991 case →0/8 sections
Summary not yet generated.
- US111100811 case →0/8 sections
Summary not yet generated.
- US124471281 case →0/8 sections
Summary not yet generated.
- US125277711 case →0/8 sections
Summary not yet generated.
- US107586520 cases8/8 sections
Summary of U.S. Patent 10,758,652 A comprehensive analysis of U.S. Patent 10,758,652 reveals the following details: Title: System and method for collecting plasma. Assignee: Haemonetics Corporation. Inventor: Michael Ragusa. Filing Date…
- US107924160 cases8/8 sections
Patent Summary: US 10,792,416 B2 Title: System and method for collecting plasma Assignee: Haemonetics Corp Inventor: Michael Ragusa Filing Date: October 25, 2017 Issue Date: October 6, 2020 Abstract: A method for collecting plasma includes…
- US109809260 cases8/8 sections
A concise summary of US Patent 10,980,926, including litigation activity, is provided below. Summary of US Patent 10,980,926 Title: System and method for collecting plasma Assignee: Haemonetics Corp. Inventor: Michael Ragusa Filing Date…
- US109809340 cases8/8 sections
Summary of U.S. Patent 10,980,934 A concise summary of U.S. Patent 10,980,934 is provided below, based on a review of the patent document. As of April 26, 2026, a search of the U.S. Court of Appeals for the Federal Circuit (CAFC) 2026…
- US115662760 cases8/8 sections
Patent Analyst Report: US 11,566,276 B2 Date of Analysis: 2026-05-12 Subject: United States Patent 11,566,276 B2, "Compositions and methods for analyte detection" --- 1. Patent Identification Title: Compositions and methods for analyte…
- US115662770 cases8/8 sections
Analysis of U.S. Patent 11,566,277 Report Date: May 12, 2026 This report provides a concise summary of United States Patent 11,566,277, including details of its prosecution history, an overview of its independent claims, and its current…
- US117381240 cases8/8 sections
Technical Analysis of U.S. Patent 11,738,124 Date of Analysis: May 13, 2026 This report provides a concise summary of United States Patent 11,738,124, including its key bibliographic details and a plain-language overview of its independent…
- US119382010 cases8/8 sections
Here is a concise summary of US Patent 11,938,201. Summary of US Patent 11,938,201 Title: Imaging and radiotherapeutics agents targeting fibroblast-activation protein-alpha (FAP-alpha) Assignee: The Johns Hopkins University Inventors: Xing…
- US121093840 cases8/8 sections
{"answer":"As of April 26, 2026, here is a summary of United States Patent 12,109,384: Title: Hemostasis valves and methods of use Assignee: Inari Medical, Inc. Inventors: Benjamin E. Merritt John C. Thress Paul Lubock Filing Date: March…
- US121687970 cases8/8 sections
Prosecution History Analysis File Wrapper Review for U.S. Patent No. 12,168,797 Application No.: 18/352,112 Filed: July 13, 2023 Priority Date: February 3, 2012 As the senior patent analyst assigned to this matter, I have reviewed the file…
- US121719160 cases8/8 sections
Summary of U.S. Patent 12,171,916 A thorough review of U.S. Patent 12,171,916 has been conducted. As of April 26, 2026, no records of this patent were found in the 2026 dockets of the U.S. Court of Appeals for the Federal Circuit (CAFC)…
- US121741060 cases8/8 sections
Analysis of U.S. Patent 12,174,106: Flow Cytometer Date of Analysis: May 13, 2026 Patent Number: US 12,174,106 B2 Title: Flow cytometer Assignee: Beckman Coulter, Inc. Inventor: Yong Qin Chen Filing Date: December 22, 2021 Issue Date…
- US121864740 cases8/8 sections
An analysis of U.S. Patent 12,186,474 reveals the following details regarding the invention, its ownership, and legal status. Title: System and method for collecting plasma. Assignee: Haemonetics Corp. Inventor: Michael Ragusa. Filing…
- US122643580 cases8/8 sections
Summary of U.S. Patent 12,264,358 A search of the United States Patent and Trademark Office (USPTO) database and the Court of Appeals for the Federal Circuit (CAFC) 2026 dockets for patent number 12264358 did not yield any direct results…
- US122905980 cases8/8 sections
An analysis of U.S. Patent 12,290,598 reveals the following details regarding the invention and its legal status. Title: Orally administered corticosteroid compositions Assignee: Ellodi Pharmaceuticals, L.P. Inventors: Stephen Perrett…
- US123772040 cases8/8 sections
A concise summary of US Patent 12377204 is as follows: Title: System and method for collecting plasma Assignee: Haemonetics Corp Inventor: Michael Ragusa Filing Date: March 12, 2025 Issue Date: August 5, 2025 Abstract: A method for…
- US124090140 cases7/8 sections
Technical Analysis of U.S. Patent 12,409,014 Date of Analysis: April 26, 2026 Patent Number: 12,409,014 Title: Systems and methods for orthodontic bracket design Assignee: The patent was initially assigned to Lightforce Orthodontics Inc…
- US12409014B20 cases7/8 sections
Patent Summary: US 12,409,014 B2 Title: Systems and methods for orthodontic bracket design Assignee: The patent was initially assigned to Lightforce Orthodontics Inc. and later records show a security interest assignment to Trinity Capital…
- US110214370 cases6/8 sections
Summary of U.S. Patent 11,021,437 A concise summary of U.S. Patent 11,021,437 is provided below, including details on the patent's title, assignee, inventor, key dates, abstract, and a plain-language overview of its independent claims…
- US110217370 cases6/8 sections
Analysis of U.S. Patent 11,021,737 Washington, D.C. - A detailed analysis of U.S. Patent No. 11,021,737 reveals a significant invention in the field of molecular biology and diagnostics, focusing on methods for detecting multiple analytes…
- US114842840 cases6/8 sections
A concise summary of US Patent 11,484,284 is provided below, based on a review of the patent records. Title: Methods and devices for processing heart sounds Assignee: Florida International University FIU Inventors: Valentina Dargam, Joshua…
- US118061200 cases3/8 sections
Here is a concise summary of U.S. Patent 11,806,120. Title: Health risk indicator determination Assignee: Beijing Shunyuan Kaihua Technology Co Ltd Inventors: Ulrik Wisløff, Christian Ragnar Gutvik Filing Date: February 4, 2021 Issue Date…
- US112351100 cases1/8 sections
Here is a concise summary of US Patent 11,235,110. Summary of US Patent 11,235,110 Title: Delivery system for ayahuasca-like substances Assignee: Monster Color Carnival LLC Inventors: Gregory Ellis Filing Date: August 4, 2021 Issue Date…
- US113445520 cases1/8 sections
An analysis of US Patent 11,344,552 reveals a targeted therapy for pancreatic cancer, currently facing legal challenges. Patent Details: Title: Methods for treating metastatic pancreatic cancer using combination therapies comprising…